News | March 30, 2022
TDB approves funding for MIM in MedTech
Technology Development Board supports commercialisation of Metal Injection Molding of implants
Technology Development Board supports commercialisation of Metal Injection Molding of implants
The company’s differentiated value proposition comes during a time of unprecedented disruption in the life science supply chain
The investment will improve equipment efficiency and increase safety standards at its Lestrem site
New inhalers would have near-zero Global Warming Potential propellant
ImmunIgY, has been developed by ReaGene Biosciences, Kyntox Bio and ProdigY, and is an antibody-containing beverage that can potentially prevent viral entry, regardless of vaccination or infection status
Market data indicates that more than twenty percent of the new chemical entities being developed use roller compaction technology in their development and commercialization
The total cost of the project is estimated at Rs 30 crore
The company plans to expand their capacity to meet the needs of pharma and biotech industries
Zydus Wellness Limited has reported consolidated financial results for the period ended September 30, 2021
The BiCNU brand and generic market had U.S. sales of approximately US $ 19.4 million MAT for the most recent twelve months ending in August 2021, according to IQVIA Health
Subscribe To Our Newsletter & Stay Updated
